These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3890049

  • 21. Effects of prazosin and alphamethyldopa on blood lipids and lipoproteins in hypertensive patients.
    Velasco M, Silva H, Feldstein E, Pellicer R, Morillo J, Urbina-Quintana A, Hernández-Pieretti O.
    Eur J Clin Pharmacol; 1985; 28(5):513-6. PubMed ID: 3899672
    [Abstract] [Full Text] [Related]

  • 22. Effects of bunazosin and atenolol on serum lipids and apolipoproteins in a randomised trial.
    Schmitz G, Stumpe KO, Herrmann W, Weidinger G.
    Blood Press; 1996 Nov; 5(6):354-9. PubMed ID: 8973753
    [Abstract] [Full Text] [Related]

  • 23. Changes in serum lipid levels during antihypertensive therapy.
    Med J Aust; 1984 Apr 28; 140(9):522-4. PubMed ID: 6369095
    [Abstract] [Full Text] [Related]

  • 24. Forearm and finger hemodynamics, blood pressure control, and lipid changes in diabetic hypertensive patients treated with atenolol and prazosin. A brief report.
    Kwan CM, Shepherd AM, Johnson J, Taylor WF, Brockway BA.
    Am J Med; 1989 Jan 23; 86(1B):55-8. PubMed ID: 2913773
    [Abstract] [Full Text] [Related]

  • 25. Effect of prazosin on blood lipids and on thyroid function in hypertensive patients.
    Velasco M, Silva H, Morillo J, Pellicer R, Urbina-Quintana A, Hernández-Pieretti O.
    J Cardiovasc Pharmacol; 1982 Jan 23; 4 Suppl 2():S225-7. PubMed ID: 6177961
    [Abstract] [Full Text] [Related]

  • 26. Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol.
    Välimäki M, Maass L, Harno K, Nikkilä EA.
    Eur J Clin Pharmacol; 1986 Jan 23; 30(1):17-20. PubMed ID: 3709628
    [Abstract] [Full Text] [Related]

  • 27. A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension.
    Ligueros M, Unwin R, Wilkins MR, Humphreys J, Coles SJ, Cleland J.
    Clin Auton Res; 1992 Dec 23; 2(6):373-81. PubMed ID: 1290920
    [Abstract] [Full Text] [Related]

  • 28. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    Br J Clin Pharmacol; 1982 Dec 23; 13(Suppl 2):441S-444S. PubMed ID: 7104158
    [Abstract] [Full Text] [Related]

  • 29. The long-term antihypertensive effects of prazosin and atenolol.
    Itskovitz HD, Krug K, Khoury S, Mollura JL.
    Am J Med; 1989 Jan 23; 86(1B):82-6. PubMed ID: 2913776
    [Abstract] [Full Text] [Related]

  • 30. Effect of beta-blockers on plasma lipids.
    Pasotti C, Zoppi A, Capra A, Rebagliati M, Fogari R.
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug 23; 24(8):448-52. PubMed ID: 3759280
    [Abstract] [Full Text] [Related]

  • 31. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
    Fogari R, Zoppi A, Malamani GD, Marasi G, Vanasia A, Villa G.
    Br J Clin Pharmacol; 1995 May 23; 39(5):471-6. PubMed ID: 7669481
    [Abstract] [Full Text] [Related]

  • 32. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
    Rouffy J, Bakir R, Chanu B, Djian F, Goy-Loeper J, Henry Amar M, Renon D, Pappo M.
    Pathol Biol (Paris); 1986 Apr 23; 34(4):253-8. PubMed ID: 3529000
    [Abstract] [Full Text] [Related]

  • 33. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Apr 23; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 34. The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension.
    Houston MC, Burger C, Hays JT, Nadeau J, Swift L, Bradley CA, Olafsson L.
    Am Heart J; 1990 Jul 23; 120(1):172-9. PubMed ID: 2193493
    [Abstract] [Full Text] [Related]

  • 35. Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men.
    Andersen P, Seljeflot I, Herzog A, Arnesen H, Hjermann I, Holme I.
    J Cardiovasc Pharmacol; 1998 May 23; 31(5):677-83. PubMed ID: 9593066
    [Abstract] [Full Text] [Related]

  • 36. [Change in the spectrum of lipids and apoproteins A1 and B as affected by hypothiazide and pratsiol in patients with hypertension].
    Oganov RG, Mustafaev II, Perova NV, Postol'nikov SF, Metel'skaia VA.
    Kardiologiia; 1985 Aug 23; 25(8):17-22. PubMed ID: 4068453
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED.
    Arch Intern Med; 1999 Mar 22; 159(6):551-8. PubMed ID: 10090111
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control.
    Diabetologia; 1996 Dec 22; 39(12):1554-61. PubMed ID: 8960842
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.